- Home
- ADN vs AIMD Comparison
ADN vs AIMD Comparison
Compare ADN & AIMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ADN
- AIMD
- Stock Information
- Founded
- ADN 2006
- AIMD 1984
- Country
- ADN United States
- AIMD United States
- Employees
- ADN N/A
- AIMD N/A
- Industry
- ADN Power Generation
- AIMD Biotechnology: Pharmaceutical Preparations
- Sector
- ADN Utilities
- AIMD Health Care
- Exchange
- ADN Nasdaq
- AIMD Nasdaq
- Market Cap
- ADN 7.5M
- AIMD 8.2M
- IPO Year
- ADN N/A
- AIMD N/A
- Fundamental
- Price
- ADN $2.80
- AIMD $0.54
- Analyst Decision
- ADN
- AIMD
- Analyst Count
- ADN 0
- AIMD 0
- Target Price
- ADN N/A
- AIMD N/A
- AVG Volume (30 Days)
- ADN 48.2K
- AIMD 201.3K
- Earning Date
- ADN 12-27-2024
- AIMD 05-16-2025
- Dividend Yield
- ADN N/A
- AIMD N/A
- EPS Growth
- ADN N/A
- AIMD N/A
- EPS
- ADN N/A
- AIMD N/A
- Revenue
- ADN $8,157,000.00
- AIMD $20,729.00
- Revenue This Year
- ADN $2,232.99
- AIMD N/A
- Revenue Next Year
- ADN $91.56
- AIMD N/A
- P/E Ratio
- ADN N/A
- AIMD N/A
- Revenue Growth
- ADN 274.35
- AIMD N/A
- 52 Week Low
- ADN $1.71
- AIMD $0.40
- 52 Week High
- ADN $8.79
- AIMD $1.46
- Technical
- Relative Strength Index (RSI)
- ADN 47.23
- AIMD 50.03
- Support Level
- ADN $2.49
- AIMD $0.51
- Resistance Level
- ADN $4.00
- AIMD $0.57
- Average True Range (ATR)
- ADN 0.42
- AIMD 0.03
- MACD
- ADN 0.19
- AIMD -0.00
- Stochastic Oscillator
- ADN 44.19
- AIMD 37.00
About ADN Advent Technologies Holdings Inc.
Advent Technologies Holdings Inc is an innovation-driven company in the fuel cell and hydrogen technology space. The company develops, manufactures, and assembles complete fuel cell systems and the critical components that determine the performance of hydrogen fuel cells and other energy systems. It serves automotive; aviation and power generation industries. It generates revenue from the sale of fuel cell systems and the sale of MEAs, membranes, and electrodes for specific applications in the fuel cell and energy storage (flow battery) markets.
About AIMD Ainos Inc.
Ainos Inc is engaged in developing biologics for the treatment of human and animal diseases. The company mainly focuses on the research of the treatment of human disease indications, particularly influenza, hepatitis C, thrombocytopenia, and other indications using natural human interferon-alpha that is administered in a proprietary low-dose oral form. Its product pipeline includes VELDONA Pet cytoprotein supplements for pets, VELDONA human therapeutics for clinical use, and telehealth-friendly POCTs powered by the AI Nose technology platform.